Cero Therapeutics

Developer of platforms for cellular immunotherapy

placeSan Francisco, California, United States calendar_todayFounded 2016 groups15 employees language cero.bio

Registered entities

Innovation

17 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,665 times.

YearFilings
20181
20196
20204
20216
20228
20238
20247
20252

Social engagement

Social engagement: 3.4K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%

Recent activity

15 Jun 2026
Milestone
regulatory
28 May 2026
Milestone
regulatory
Coming soon